A detailed history of Virginia Retirement Systems Et Al transactions in Arvinas, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 15,000 shares of ARVN stock, worth $158,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,000
Holding current value
$158,550
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025

BUY
$6.24 - $8.53 $93,600 - $127,949
15,000 New
15,000 $127,000
Q1 2025

Jul 16, 2025

BUY
$7.02 - $20.5 $203,580 - $594,500
29,000 New
29,000 $203,000
Q1 2021

Apr 30, 2021

SELL
$58.19 - $91.37 $221,122 - $347,206
-3,800 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$20.19 - $84.93 $147,387 - $619,989
-7,300 Reduced 65.77%
3,800 $323,000
Q3 2020

Nov 12, 2020

SELL
$22.99 - $36.34 $73,568 - $116,288
-3,200 Reduced 22.38%
11,100 $262,000
Q2 2020

Aug 12, 2020

BUY
$29.88 - $56.74 $427,284 - $811,382
14,300 New
14,300 $480,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $562M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.